Cargando…
Severe refractory autoimmune hemolytic anemia with both warm and cold autoantibodies that responded completely to a single cycle of rituximab: a case report
INTRODUCTION: Mixed warm and cold autoimmune hemolytic anemia runs a chronic course with severe intermittent exacerbations. Therapeutic options for the treatment of hemolysis associated with autoimmune hemolytic anemia are limited. There have been only two reported cases of the effective use of ritu...
Autores principales: | Gupta, Shilpi, Szerszen, Anita, Nakhl, Fadi, Varma, Seema, Gottesman, Aaron, Forte, Frank, Dhar, Meekoo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096571/ https://www.ncbi.nlm.nih.gov/pubmed/21504611 http://dx.doi.org/10.1186/1752-1947-5-156 |
Ejemplares similares
-
Rituximab Use in Warm and Cold Autoimmune Hemolytic Anemia
por: Murakhovskaya, Irina
Publicado: (2020) -
Cold autoimmune hemolytic anemia resolved by rituximab
por: Palombi, Massimiliano, et al.
Publicado: (2010) -
Case report: Autoimmune hemolytic anemia caused by warm and cold autoantibodies with complement activation—etiological and therapeutic issues
por: Turudic, Daniel, et al.
Publicado: (2023) -
Warm and Cold Autoimmune Hemolytic Anemia in the Setting of COVID-19 Disease
por: Brazel, Danielle, et al.
Publicado: (2021) -
Novel Monoclonal Antibody Therapy in a Patient With Treatment-Refractory Warm Autoimmune Hemolytic Anemia
por: Tahhan, Fadi, et al.
Publicado: (2022)